PMID- 11316851 OWN - NLM STAT- MEDLINE DCOM- 20010809 LR - 20210511 IS - 1046-6673 (Print) IS - 1046-6673 (Linking) VI - 12 IP - 5 DP - 2001 May TI - Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. PG - 932-940 LID - 10.1681/ASN.V125932 [doi] AB - Wegener's granulomatosis is an autoimmune disease that is characterized by systemic vasculitis and granuloma formation. Early influx of polymorphonuclear neutrophils (PMN), followed at a later stage by mononuclear cells, contributes to the granulomatous inflammation. Previous studies have shown that proteinase 3 (PR3), the major autoantigen in Wegener's granulomatosis, specifically binds to endothelial cells and plays a possible role in activation of these cells by enhancing interleukin-8 production, thus providing a chemotactic and activating stimulus for PMN. The present study demonstrated that PR3 enhances the production of monocyte chemoattractant protein-1 (MCP-1) by human umbilical vein endothelial cells (HUVEC) in a dose- and time-dependent manner. The PR3-induced increase in MCP-1 production was demonstrated at both the protein and the mRNA levels and was chemotactic for monocytes. In addition, it was demonstrated that PR3 induces a dose- and time-dependent increase in the expression of intercellular adhesion molecule-1 (ICAM-1) as determined by fluorescence-activated cell sorter analysis. The PR3-induced increase in expression of ICAM-1 was also demonstrated at the mRNA level. PR3 induced a slight increase in vascular cell adhesion molecule-1 expression and had no effect on the expression of both P- and E-selectin. Incubation of HUVEC for 24 h in the presence of PR3 resulted in a significant increase in adhesion of PMN, which was reduced to baseline levels in the presence of blocking monoclonal antibody anti-ICAM-1 or anti-CD18 or a combination of both. Monocytes showed a slight but statistically not significant increase in adhesion. Incubation of HUVEC with PR3 for 4 h did not result in enhanced adhesion of either PMN or monocytes. It was hypothesized that PR3, which may be released locally at inflammatory sites after activation of cytokine primed PMN, plays a role in endothelial cell activation by enhancing both interleukin-8 and MCP-1 production, thus providing a chemotactic and activating stimulus for both PMN and monocytes. In addition, PR3 may contribute to the ongoing inflammation by enhancing the adhesion of PMN to endothelial cells by upregulating ICAM-1 expression. FAU - Taekema-Roelvink, Miriam E J AU - Taekema-Roelvink MEJ AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Kooten, Cees VAN AU - Kooten CV AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Kooij, Sandra VAN DER AU - Kooij SV AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Heemskerk, Evert AU - Heemskerk E AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Daha, Mohamed R AU - Daha MR AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Am Soc Nephrol JT - Journal of the American Society of Nephrology : JASN JID - 9013836 RN - 0 (Chemokine CCL2) RN - 0 (DNA Primers) RN - 0 (RNA, Messenger) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - EC 3.4.21.- (Serine Endopeptidases) RN - EC 3.4.21.76 (Myeloblastin) SB - IM MH - Base Sequence MH - Cell Adhesion MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis/genetics MH - DNA Primers/genetics MH - Endothelium, Vascular/cytology/drug effects/metabolism MH - Granulomatosis with Polyangiitis/etiology/genetics/metabolism MH - Humans MH - In Vitro Techniques MH - Intercellular Adhesion Molecule-1/genetics/*metabolism MH - Monocytes/cytology/drug effects/metabolism MH - Myeloblastin MH - Neutrophils/*cytology/drug effects/metabolism MH - RNA, Messenger/genetics/metabolism MH - Serine Endopeptidases/*metabolism/pharmacology MH - Up-Regulation EDAT- 2001/04/24 10:00 MHDA- 2001/08/10 10:01 CRDT- 2001/04/24 10:00 PHST- 2001/04/24 10:00 [pubmed] PHST- 2001/08/10 10:01 [medline] PHST- 2001/04/24 10:00 [entrez] AID - 12/5/932 [pii] AID - 10.1681/ASN.V125932 [doi] PST - ppublish SO - J Am Soc Nephrol. 2001 May;12(5):932-940. doi: 10.1681/ASN.V125932.